HomeIMUX • NASDAQ
add
Immunic Inc
Previous close
$1.30
Day range
$1.26 - $1.34
Year range
$0.95 - $3.11
Market cap
121.68M USD
Avg Volume
248.56K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 23.38M | -4.01% |
Net income | -21.57M | 61.80% |
Net profit margin | — | — |
Earnings per share | -0.48 | 18.35% |
EBITDA | -23.36M | 4.03% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 46.67M | -59.89% |
Total assets | 54.30M | -57.50% |
Total liabilities | 25.37M | 80.31% |
Total equity | 28.93M | — |
Shares outstanding | 89.93M | — |
Price to book | 2.03 | — |
Return on assets | -96.40% | — |
Return on capital | -145.91% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -21.57M | 61.80% |
Cash from operations | -14.03M | 7.13% |
Cash from investing | -165.00K | 98.29% |
Cash from financing | 604.00K | -98.92% |
Net change in cash | -13.02M | -138.31% |
Free cash flow | -6.52M | 13.59% |
About
CEO
Founded
May 2003
Website
Employees
77